Lexicon Pharmaceuticals, INC. 8-K Filing

Ticker: LXRX · Form: 8-K · Filed: Nov 10, 2025

Sentiment: neutral

Filing Stats: 640 words · 3 min read · ~2 pages · Grade level 13.2 · Accepted 2025-11-10 16:31:01

Key Financial Figures

$0.001 — ich registered Common stock, par value $0.001 LXRX The Nasdaq Capital Market Che
$0 — , shares of its common stock, par value $0.001, having an aggregate sales price of
$75,000,000 — aving an aggregate sales price of up to $75,000,000 (the "Shares"), filed a prospectus supp

Filing Documents

d30705d8k.htm (8-K) — 23KB
0001193125-25-274383.txt ( ) — 134KB
lxrx-20251106.xsd (EX-101.SCH) — 3KB
lxrx-20251106_lab.xml (EX-101.LAB) — 18KB
lxrx-20251106_pre.xml (EX-101.PRE) — 11KB
d30705d8k_htm.xml (XML) — 4KB

Signatures

Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Lexicon Pharmaceuticals, Inc. Date: November 10, 2025 By: /s/ Brian T. Crum Brian T. Crum Senior Vice President and General Counsel